Elicio Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,166 | $0 |
Gross Profit | -281 | -278 | 583 | -290 |
EBITDA | -10,091 | -10,755 | -13,465 | -18,411 |
EBIT | -10,372 | -11,033 | -13,770 | -18,701 |
Net Income | -10,561 | -11,209 | -14,004 | -18,838 |
Net Change In Cash | 0 | 0 | 1,166 | 0 |
Free Cash Flow | -8,950 | -10,119 | -8,789 | -7,274 |
Cash | 22,088 | 18,351 | 17,618 | 26,016 |
Basic Shares | 16,059 | 12,950 | 12,202 | 13,582 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $28,312 |
Gross Profit | -1,178 | -1,170 | -1,057 | 27,078 |
EBITDA | -50,265 | -32,966 | -23,554 | -51,925 |
EBIT | -51,443 | -34,136 | -24,611 | -52,726 |
Net Income | -51,898 | -35,195 | -28,207 | -26,400 |
Net Change In Cash | 0 | 0 | 0 | 28,312 |
Free Cash Flow | -37,155 | -32,760 | -22,833 | -24,464 |
Cash | 17,618 | 12,894 | 6,155 | 9,278 |
Basic Shares | 12,202 | 5,056 | 3,100 | 3,200 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.66 |
2025-03-31 | -$0.87 |
2024-12-31 | -$1.02 |
2024-09-30 | -$1.39 |
